Related Experiment Video
Updated: Aug 14, 2025
09:56
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
706
Chimeric antigen receptor-based therapies beyond cancer
María Velasco-de Andrés1, Guillermo Muñoz-Sánchez2, Laura Carrillo-Serradell1
1Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
European Journal of Immunology
|January 17, 2023
Summary
Chimeric antigen receptor (CAR) technology enhances adoptive cell transfer (ACT) therapies beyond cancer. This review explores CAR-based ACT applications in infection, allergy, autoimmunity, transplantation, and fibrotic repair, discussing current research and limitations.
Failed At:
2026-06-19T13:39:57.470981+00:00
Related Concept Videos
01:27Tumor Immunotherapy
619
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
619
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K